pazopanib 200 MG Oral Tablet [Votrient]

RxCUI: 867506
RxNorm name: pazopanib 200 MG Oral Tablet [Votrient]
Display name: pazopanib 200 MG Oral Tablet [Votrient]
Full name: pazopanib 200 MG Oral Tablet [Votrient]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
VOTRIENT	PAZOPANIB HYDROCHLORIDE	Novartis Pharmaceuticals Corporation	eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7	2025-12-16	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 867506

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7	Votrient 200 MG Oral Tablet [PSN] · pazopanib 200 MG Oral Tablet [Votrient] [SBD] · Votrient 200 MG Oral Tablet [SY]	3	15	These highlights do not include all the information needed to use VOTRIENT safely and effectively. See full prescribing information for VOTRIENT. VOTRIENT ® (pazopanib) tablets, for oral use Initial U.S. Approval: 2009	20251216